Nashville Medical Research Institute

Nashville, Tennessee 37211

0 studies enrolling now · 39 studies all time

What they study most

Arthritis, Rheumatoid, Chronic Constipation, Chronic Hepatitis C, Chronic Idiopathic Constipation, Colitis, Ulcerative, Colonoscopy, Conscious Sedation, Crohn Disease, Crohn's Disease, Diverticulitis, Dyslipidemia, Endoscopy, Digestive System

Studies at this site

• Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease — Completed
• Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs — Completed
• Prevention of Recurrence of Diverticulitis — Completed
• Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients — Completed
• SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation — Completed
• Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
• Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis — Completed
• New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis — Completed
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study — Completed
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay — Completed
• Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus — Completed
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials — Completed
• Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing — Completed
• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed
• Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients — Completed
• Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment — Completed
• Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy — Completed
• Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis — Completed
• Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C — Completed
• Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis — Completed
• Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection — Completed
• Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients — Completed
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis — Completed
• Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis — Status unconfirmed
• Remission in Subjects With Crohn's Disease, 1 Year Phase — Completed
• Remission in Subjects With Crohn's Disease, Open Label Extension — Completed
• Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy — Completed
• Obese Patients With Untreated Dyslipidemias — Completed
• Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease — Completed
• An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease — Completed
• A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease — Completed
• STA-5326 in Crohn's Disease Patients — Completed